Daily Signals
2479 companies scored · 2026-10-15 run in progress: 2144 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D
Distribution of the day's forecasts
30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
2479 companies
Sorted by market cap ↓ · forecast rankings are part of the paid plans
| Ticker | Rating | 30D | Δ | |
|---|---|---|---|---|
| CPRICapri Holdings Ltd | +0.91% | · | ||
| BLBLACKLINE, INC. | +1.03% | · | ||
| XHRXenia Hotels & Resorts, Inc. | +1.01% | · | ||
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | Unlock rating and forecasts | |||
| PSNLPersonalis, Inc. | Unlock rating and forecasts | |||
| SEPNSepterna, Inc. | Unlock rating and forecasts | |||
| STBAS&T BANCORP INC | +0.94% | · | ||
| HOPEHOPE BANCORP INC | +0.83% | · | ||
| ARDTArdent Health, Inc. | +0.86% | · | ||
| ALNTALLIENT INC | Unlock rating and forecasts | |||
| XRAYDENTSPLY SIRONA Inc. | +0.86% | · | ||
| DCOMDime Commercial Bancshares, Inc. /NY/ | +0.98% | · | ||
| NEXANexa Resources S.A. | Unlock rating and forecasts | |||
| PLABPHOTRONICS INC | Unlock rating and forecasts | |||
| FLOCFlowco Holdings Inc. | +0.77% | · | ||
| GICGLOBAL INDUSTRIAL Co | Unlock rating and forecasts | |||
| EVCMEverCommerce Inc. | +1.05% | · | ||
| BYBYLINE BANCORP, INC. | +0.97% | · | ||
| NUVBNuvation Bio Inc. | Unlock rating and forecasts | |||
| HAPNHappen, Inc. | Unlock rating and forecasts | |||
| ATEXAnterix Inc. | +1.01% | · | ||
| TGLSTecnoglass Holdings Inc. | Unlock rating and forecasts | |||
| NEXTNextDecade Corp | Unlock rating and forecasts | |||
| AZTAAzenta, Inc. | Unlock rating and forecasts | |||
| CNXCConcentrix Corp | +1.10% | · | ||
| ZBIOZenas BioPharma, Inc. | +1.05% | · | ||
| BFCBank First Corp | Unlock rating and forecasts | |||
| AVEXAEVEX Corp. | +0.84% | · | ||
| GLOBGlobant S.A. | +1.05% | · | ||
| OMCLOMNICELL, INC. | +0.75% | · | ||
| KOSKosmos Energy Ltd. | Unlock rating and forecasts | |||
| ATECAlphatec Holdings, Inc. | Unlock rating and forecasts | |||
| NOMDNomad Foods Ltd | +0.81% | · | ||
| NVCRNovoCure Ltd | Unlock rating and forecasts | |||
| ANIPANI PHARMACEUTICALS INC | Unlock rating and forecasts | |||
| WBWEIBO Corp | Unlock rating and forecasts | |||
| GENBGenerate Biomedicines, Inc. | Unlock rating and forecasts | |||
| HUBGHub Group, Inc. | Unlock rating and forecasts | |||
| NTLAIntellia Therapeutics, Inc. | Unlock rating and forecasts | |||
| LOBLive Oak Bancshares, Inc. | Unlock rating and forecasts | |||
| QCRHQCR HOLDINGS INC | Unlock rating and forecasts | |||
| LILALiberty Latin America Ltd. | +0.88% | · | ||
| GSHDGoosehead Insurance, Inc. | Unlock rating and forecasts | |||
| EFOREverforth Inc | Unlock rating and forecasts | |||
| OCULOCULAR THERAPEUTIX, INC | Unlock rating and forecasts | |||
| CTSCTS CORP | +1.05% | · | ||
| WLTHWEALTHFRONT CORP | Unlock rating and forecasts | |||
| OBKOrigin Bancorp, Inc. | +0.98% | · | ||
| KEELKeel Infrastructure Corp. | Unlock rating and forecasts | |||
| CMPSCOMPASS Pathways plc | Unlock rating and forecasts | |||
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-14) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.